Lucrative Asian Markets to Offer Significant Growth Opportunities for the Antibody Production Market in the Coming Years

Antibodies are indispensable tools to carry out diagnostic tests for infectious diseases such as HIV, congenital CMV, and coeliac disease. In addition, pharmaceutical and biopharmaceutical research uses antibodies for drug discovery and development, especially for the development of monoclonal antibody (mAb) drugs.

Download Free Sample Copy of report @ http://www.marketsandmarkets.com/pdfdownload.asp?id=181543091

Growth in the antibody production market is likely to be centered in the Asian region. This growth in Asia can be attributed to factors such as rising biomedical and medical research in Japan; increasing government and private-sector funding in China’s life sciences market; booming pharmaceutical industry, increasing funds for biotechnology, and development of bioclusters in India; rising pharmaceutical and biotechnology R&D activities in Korea; government support for academic and commercial R&D activities in Taiwan; and the expansion of leading companies in Singapore.

Speak to Research Analyst for More Details @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=181543091

China’s leading research institutes and universities are pursuing innovation and development of novel drugs for the commercial market. From 2010 to 2012, various government agencies in China invested $40 billion per year in the life sciences industry, adding to over $10 billion in investments from commercial sources (Source: ChinaBio Today). Moreover, through the 12th Five-Year Plan in China, the biotechnology industry will be given financial support and government industrial policy incentives. Apart from this, increasing contributions are being made by the private sector through venture capital investments, corporate investments, and mergers and acquisitions.

The Indian pharmaceutical industry is expected to reach $20 billion by 2015 (Source: Associated Chambers of Commerce and Industry (ASSOCHAM)). In addition, India has taken strong initiatives to develop bioclusters based on core academic and entrepreneurial strengths. These clusters provide an encouraging platform for biotechnology companies to conduct innovative research studies, particularly drug discovery and development.

Korea is highly focused on developing its biotechnology and pharmaceutical sectors, which can be witnessed through its government initiatives like Pharma 2020 Vision and Bio-Vision 2016. Moreover, in February 2014, AbbVie, a spinoff of Abbott Laboratories, acquired an API facility in Singapore’s Tuas Biomedical Park. At this facility, the company built a $320 million biologics plant which is expected to support its antibody-drug conjugate (ADC) pipeline. AbbVie’s expansion in Singapore to support the ADC pipeline is likely to propel the market for antibody production in the country, which in turn boosts the market in Asia.

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com